About Us
The life sciences regulatory landscape is rigorous and constantly changes. As a strategic partner for life science companies, our flexible team of experienced advisors leverage decades of clinical,scientific, industry, FDA and global regulatory authority knowledge to help our partners and clients strategically navigate a highly complex regulatory environment, while also balancing risk, speed and cost to achieve successful outcomes.
Most Drugs being developed in clinical research Trials fail to make it to market
In several therapeutic areas including diabetes mellitus, cardiovascular disease, hypertension, hyperlipidemia, fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), Inflammatory Bowel Disease, Crohn’s Disease, Ulcerative Colitis, Migraine Headache, Neuropathic Pain, COPD, and Alzheimer’s Disease.
Dr. Weston currently participates in key aspects of the clinical research drug development process that ultimately helps pharmaceutical drug companies to successfully bring new drugs and medical devices to the market. He participates in Phase 1, Phase 2, Phase 3, and Phase 4 clinical trials.
Schedule An Exploratory Call
Get the Insights and Answers you need to make critical decisions about your project
Get started on a successful development project
Clinical Trial Services
Medical Writing
Biostatistics
eCTD Submission
NDA Application
BLA Application
Blog
Research Site Selection for Optimal Subject Enrollment – Challenges & Solutions
